A nomogram for predicting the risk of major postoperative complications for patients with meningioma.


Journal

Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181

Informations de publication

Date de publication:
31 Oct 2023
Historique:
received: 24 02 2023
accepted: 22 10 2023
revised: 25 09 2023
medline: 2 11 2023
pubmed: 1 11 2023
entrez: 1 11 2023
Statut: epublish

Résumé

To identify risk factors for major postoperative complications in meningioma patients and to construct and validate a nomogram that identify patients at high risk of these complications. The medical records of meningioma patients who underwent surgical resection in our hospital from January 2018 to December 2020 were collected. The patients were divided into a training set (815 cases from the main campus in 2018 and 2019) and a validation set (300 cases from two other campuses in 2020). Major postoperative complications were defined as any new neurological deficits and complications classified as Clavien-Dindo Grading (CDG) II or higher. Univariate and multivariate analyses were conducted using the training set to identify independent risk factors. A nomogram was constructed based on these results. And then validated the nomogram through bootstrap re-sampling in both the training and validation sets. The concordance index (C-index) and the area under the curve (AUC) were used to assess the discriminative ability of the nomogram. The Hosmer-Lemeshow test was performed to evaluate the goodness-of-fit. The optimal cutoff point for the nomogram was calculated using Youden's index. In the training set, 135 cases (16.56%) experienced major postoperative complications. The independent risk factors identified were male sex, recurrent tumors, American Society of Anesthesiologists (ASA) class III-IV, preoperative Karnofsky Performance Scale (KPS) score < 80, preoperative serum albumin < 35 g/L, tumor in the skull base or central sulcus area, subtotal tumor resection (STR), allogeneic blood transfusion, and larger tumor size. A nomogram was constructed based on these risk factors. It demonstrated good predictive performance, with a C-index of 0.919 for the training set and 0.872 for the validation set. The area under the curve (AUC) > 0.7 indicated satisfactory discriminative ability. The Hosmer-Lemeshow test showed no significant deviation from the predicted probabilities. And the cutoff for nomogram total points was about 200 (specificity 0.881 and sensitivity 0.834). The constructed nomogram demonstrated robust predictive performance for major postoperative complications in meningioma patients. This model can be used by surgeons as a reference in clinical decision-making.

Identifiants

pubmed: 37907646
doi: 10.1007/s10143-023-02198-8
pii: 10.1007/s10143-023-02198-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

288

Subventions

Organisme : the Natural Science Foundation of Tongji Hospital
ID : No. 2020JZKT420
Organisme : the Natural Science Foundation of Tongji Hospital
ID : No. 2020JZKT420
Organisme : the Natural Science Foundation of Tongji Hospital
ID : No. 2020JZKT420
Organisme : the Natural Science Foundation of Tongji Hospital
ID : No. 2020JZKT420

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2020) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol 22:iv1–iv96. https://doi.org/10.1093/neuonc/noaa200
doi: 10.1093/neuonc/noaa200 pubmed: 33123732 pmcid: 7596247
Bateman BT, Pile-Spellman J, Gutin PH, Berman MF (2005) Meningioma resection in the elderly: nationwide inpatient sample, 1998–2002. Neurosurgery 57:866–872. https://doi.org/10.1227/01.neu.0000179923.66729.87 . (discussion 866-872)
doi: 10.1227/01.neu.0000179923.66729.87 pubmed: 16284557
Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M, Moyal EC-J, Brandsma D, Henriksson R, Soffietti R, Weller M (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17:e383–e391. https://doi.org/10.1016/s1470-2045(16)30321-7
doi: 10.1016/s1470-2045(16)30321-7 pubmed: 27599143
Lemee JM, Corniola MV, Da Broi M, Schaller K, Meling TR (2019) Early postoperative complications in meningioma: predictive factors and impact on outcome. World Neurosurg 128:e851–e858. https://doi.org/10.1016/j.wneu.2019.05.010
doi: 10.1016/j.wneu.2019.05.010 pubmed: 31082552
Isobe N, Ikawa F, Tominaga A, Kuroki K, Sadatomo T, Mizoue T, Hamasaki O, Matsushige T, Abiko M, Mitsuhara T, Kinoshita Y, Takeda M, Kurisu K (2018) Factors related to frailty associated with clinical deterioration after meningioma surgery in the elderly. World Neurosurg 119:e167–e173. https://doi.org/10.1016/j.wneu.2018.07.080
doi: 10.1016/j.wneu.2018.07.080 pubmed: 30031190
Jenkins FS, Vasella F, Padevit L, Mutschler V, Akeret K, Velz J, Regli L, Sarnthein J, Neidert MC (2021) Preoperative risk factors associated with new focal neurological deficit and other major adverse events in first-time intracranial meningioma neurosurgery. Acta Neurochir (Wien) 163:2871–2879. https://doi.org/10.1007/s00701-021-04897-x
doi: 10.1007/s00701-021-04897-x pubmed: 34259901
Zeng L, Wang L, Ye F, Chen J, Lei T, Chen J (2015) Clinical characteristics of patients with asymptomatic intracranial meningiomas and results of their surgical management. Neurosurg Rev 38:481–488. https://doi.org/10.1007/s10143-015-0619-1 . (discussion 488)
doi: 10.1007/s10143-015-0619-1 pubmed: 25697143
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 15273542 pmcid: 1360123
Sarnthein J, Stieglitz L, Clavien PA, Regli L (2016) A patient registry to improve patient safety: recording general neurosurgery complications. Plos One 11:e0163154. https://doi.org/10.1371/journal.pone.0163154
doi: 10.1371/journal.pone.0163154 pubmed: 27669157 pmcid: 5036891
Landriel Ibanez FA, Hem S, Ajler P, Vecchi E, Ciraolo C, Baccanelli M, Tramontano R, Knezevich F, Carrizo A (2011) A new classification of complications in neurosurgery. World Neurosurg 75:709–715. https://doi.org/10.1016/j.wneu.2010.11.010 . (discussion 604-711)
doi: 10.1016/j.wneu.2010.11.010 pubmed: 21704941
Terrapon APR, Zattra CM, Voglis S, Velz J, Vasella F, Akeret K, Held U, Schiavolin S, Bozinov O, Ferroli P, Broggi M, Sarnthein J, Regli L, Neidert MC (2021) Adverse events in neurosurgery: the novel therapy-disability-neurology grade. Neurosurgery 89:236–245. https://doi.org/10.1093/neuros/nyab121
doi: 10.1093/neuros/nyab121 pubmed: 33887774
Li Y, Lu D, Feng D, Cheng H, Huang Q, Zhao H, Chen P, Qin H, Cai Q (2020) Management of incidental anterior skull base large and giant meningiomas in elderly patients. J Neurooncol 148:481–488. https://doi.org/10.1007/s11060-020-03484-x
doi: 10.1007/s11060-020-03484-x pubmed: 32529449
Demonte F, Mcdermott MW, Almefty O (2011) Al-Mefty’s meningiomas. Thieme Medical, New York
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1
doi: 10.1007/s00401-016-1545-1 pubmed: 27157931
Caroli M, Locatelli M, Prada F, Beretta F, Martinelli-Boneschi F, Campanella R, Arienta C (2005) Surgery for intracranial meningiomas in the elderly: a clinical-radiological grading system as a predictor of outcome. J Neurosurg 102:290–294. https://doi.org/10.3171/jns.2005.102.2.0290
doi: 10.3171/jns.2005.102.2.0290 pubmed: 15739557
Sacko O, Sesay M, Roux FE, Riem T, Grenier B, Liguoro D, Loiseau H (2007) Intracranial meningioma surgery in the ninth decade of life. Neurosurgery 61:950–954. https://doi.org/10.1227/01.neu.0000303190.80049.7d . (discussion 955)
doi: 10.1227/01.neu.0000303190.80049.7d pubmed: 18091271
Wilson TA, Huang L, Ramanathan D, Lopez-Gonzalez M, Pillai P, De Los RK, Kumal M, Boling W (2020) Review of atypical and anaplastic meningiomas: classification, molecular biology, and management. Front Oncol 10:565582. https://doi.org/10.3389/fonc.2020.565582
doi: 10.3389/fonc.2020.565582 pubmed: 33330036 pmcid: 7714950
Eksi MS, Canbolat C, Akbas A, Ozmen BB, Akpinar E, Usseli MI, Gungor A, Guduk M, Hacihanefioglu M, Ersen Danyeli A, Ozduman K, Pamir MN (2019) Elderly patients with intracranial meningioma: surgical considerations in 228 patients with a comprehensive analysis of the literature. World Neurosurg 132:e350–e365. https://doi.org/10.1016/j.wneu.2019.08.150
doi: 10.1016/j.wneu.2019.08.150 pubmed: 31476477
Chen ZY, Zheng CH, Tang L, Su XY, Lu GH, Zhang CY, Xiao SW, Tan YF (2015) Intracranial meningioma surgery in the elderly (over 65 years): prognostic factors and outcome. Acta Neurochir (Wien) 157:1549–1557. https://doi.org/10.1007/s00701-015-2502-9 . (discussion 1557)
doi: 10.1007/s00701-015-2502-9 pubmed: 26170189
Gousias K, Schramm J, Simon M (2016) The Simpson grading revisited: aggressive surgery and its place in modern meningioma management. J Neurosurg 125:551–560. https://doi.org/10.3171/2015.9.JNS15754
doi: 10.3171/2015.9.JNS15754 pubmed: 26824369
Song X, Zeng C, Wang M, Wang W, Lin F, He Q, Cao Y, Wang S, Zhao J (2021) Clinical characteristics and risk factors of perioperative outcomes in elderly patients with intracranial tumors. Neurosurg Rev 44:389–400. https://doi.org/10.1007/s10143-019-01217-x
doi: 10.1007/s10143-019-01217-x pubmed: 31848767
Zhao X, Zhao D, Wu Y, Gao W, Cui H, Wang Y, Nakaji P, Bao Y (2018) Meningioma in the elderly: characteristics, prognostic factors, and surgical strategy. J Clin Neurosci 56:143–149. https://doi.org/10.1016/j.jocn.2018.06.011
doi: 10.1016/j.jocn.2018.06.011 pubmed: 29958757
Yamamoto J, Takahashi M, Idei M, Nakano Y, Soejima Y, Akiba D, Kitagawa T, Ueta K, Miyaoka R, Nishizawa S (2017) Clinical features and surgical management of intracranial meningiomas in the elderly. Oncol Lett 14:909–917. https://doi.org/10.3892/ol.2017.6174
doi: 10.3892/ol.2017.6174 pubmed: 28693251 pmcid: 5494699
Kolakshyapati M, Ikawa F, Abiko M, Mitsuhara T, Kinoshita Y, Takeda M, Kurisu K, Alumni Association Group of the Department of Neurosurgery at Hiroshima U (2018) Multivariate risk factor analysis and literature review of postoperative deterioration in Karnofsky Performance Scale score in elderly patients with skull base meningioma. Neurosurg Focus 44:E14. https://doi.org/10.3171/2018.1.FOCUS17730
doi: 10.3171/2018.1.FOCUS17730 pubmed: 29606047
Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J, Schiff D, Weber DC, Wen PY, Vogelbaum MA (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 122:4–23. https://doi.org/10.3171/2014.7.JNS131644
doi: 10.3171/2014.7.JNS131644 pubmed: 25343186 pmcid: 5062955
Magill ST, Lee DS, Yen AJ, Lucas CG, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW (2018) Surgical outcomes after reoperation for recurrent skull base meningiomas. J Neurosurg 130:876–883. https://doi.org/10.3171/2017.11.JNS172278
doi: 10.3171/2017.11.JNS172278 pubmed: 29726777
Magill ST, Dalle Ore CL, Diaz MA, Jalili DD, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW (2018) Surgical outcomes after reoperation for recurrent non-skull base meningiomas. J Neurosurg: 1–9 https://doi.org/10.3171/2018.6.JNS18118
Meling TR, Da Broi M, Scheie D, Helseth E (2019) Skull base versus non-skull base meningioma surgery in the elderly. Neurosurg Rev 42:961–972. https://doi.org/10.1007/s10143-018-1005-6
doi: 10.1007/s10143-018-1005-6 pubmed: 29978438
Narayan V, Bir SC, Mohammed N, Savardekar AR, Patra DP, Nanda A (2018) Surgical management of giant intracranial meningioma: operative nuances, challenges, and outcome. World Neurosurg 110:e32–e41. https://doi.org/10.1016/j.wneu.2017.09.184
doi: 10.1016/j.wneu.2017.09.184 pubmed: 28987827
Jumah F, AbuRmilah A, Raju B, Jaber S, Adeeb N, Narayan V, Sun H, Cuellar H, Gupta G, Nanda A (2021) Does preoperative embolization improve outcomes of meningioma resection? Neurosurg Rev, A systematic review and meta-analysis. https://doi.org/10.1007/s10143-021-01519-z
doi: 10.1007/s10143-021-01519-z
Przybylowski CJ, Zhao X, Baranoski JF, Borba Moreira L, Gandhi S, Chapple KM, Almefty KK, Sanai N, Ducruet AF, Albuquerque FC, Little AS, Nakaji P (2020) Preoperative embolization versus no embolization for WHO grade I intracranial meningioma: a retrospective matched cohort study. J Neurosurg: 1–8 https://doi.org/10.3171/2020.1.JNS19788
Yoon N, Shah A, Couldwell WT, Kalani MYS, Park MS (2018) Preoperative embolization of skull base meningiomas: current indications, techniques, and pearls for complication avoidance. Neurosurg Focus 44:E5. https://doi.org/10.3171/2018.1.FOCUS17686
doi: 10.3171/2018.1.FOCUS17686 pubmed: 29606046
Dincer A, Jalal MI, Gupte TP, Vetsa S, Vasandani S, Yalcin K, Marianayagam N, Blondin N, Corbin Z, McGuone D, Fulbright RK, Erson-Omay Z, Günel M, Moliterno J (2023) The clinical and genomic features of seizures in meningiomas. Neurooncol Adv 5:i49–i57. https://doi.org/10.1093/noajnl/vdac110
doi: 10.1093/noajnl/vdac110 pubmed: 37287582 pmcid: 10243847
Schwartz TH, McDermott MW (2020) The Simpson grade: abandon the scale but preserve the message. J Neurosurg: 1–8 https://doi.org/10.3171/2020.6.Jns201904
Cataldi S, Bruder N, Dufour H, Lefevre P, Grisoli F, Francois G (1997) Intraoperative autologous blood transfusion in intracranial surgery. Neurosurgery 40:765–771. https://doi.org/10.1097/00006123-199704000-00021 . (discussion 771-762)
doi: 10.1097/00006123-199704000-00021 pubmed: 9092850
Patil H, Garg N, Navakar D, Banabokade L (2018) Clinical experience of autologous blood transfusion in neurosurgery: prospective study in Central India. World Neurosurg 115:e539–e543. https://doi.org/10.1016/j.wneu.2018.04.091
doi: 10.1016/j.wneu.2018.04.091 pubmed: 29704687
Cohen-Inbar O, Sviri GE, Soustiel JF, Zaaroor M (2011) The Geriatric Scoring System (GSS) in meningioma patients–validation. Acta Neurochir (Wien) 153:1501–1508. https://doi.org/10.1007/s00701-011-1034-1 . (discussion 1508)
doi: 10.1007/s00701-011-1034-1 pubmed: 21562736
Adachi K, Kawase T, Yoshida K, Yazaki T, Onozuka S (2009) ABC Surgical Risk Scale for skull base meningioma: a new scoring system for predicting the extent of tumor removal and neurological outcome. Clinical article. J Neurosurg 111:1053–1061. https://doi.org/10.3171/2007.11.17446
doi: 10.3171/2007.11.17446 pubmed: 19119879

Auteurs

Zheng-Qian Guo (ZQ)

Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Xiao-Yu Xia (XY)

Department of Psychology, Wuchang Hospital, Wuhan, China.

Dan Cao (D)

Department of Neurocritical Care Unit, The First Affiliated Hospital of University of Science and Technology of China, Hefei, China.

Xu Chen (X)

Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Yue He (Y)

Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Bao-Feng Wang (BF)

Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. wbf620@163.com.

Dong-Sheng Guo (DS)

Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. tjguodongsheng@163.com.

Jian Chen (J)

Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. husttjchen110@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH